Abstract:Obstructive sleep apnea syndrome (OSAS) is a common breathing disorder in sleep in which the airways narrow or collapse during sleep, causing obstructive sleep apnea. The prevalence of OSAS continues to rise worldwide, particularly in middle-aged and elderly individuals. The mechanism of upper airway collapse is incompletely understood but is associated with several factors, including obesity, craniofacial changes, altered muscle function in the upper airway, pharyngeal neuropathy, and fluid shifts to the neck. The main characteristics of OSAS are recurrent pauses in respiration, which lead to intermittent hypoxia (IH) and hypercapnia, accompanied by blood oxygen desaturation and arousal during sleep, which sharply increases the risk of several diseases. This paper first briefly describes the epidemiology, incidence, and pathophysiological mechanisms of OSAS. Next, the alterations in relevant signaling pathways induced by IH are systematically reviewed and discussed. For example, IH can induce gut microbiota (GM) dysbiosis, impair the intestinal barrier, and alter intestinal metabolites. These mechanisms ultimately lead to secondary oxidative stress, systemic inflammation, and sympathetic activation. We then summarize the effects of IH on disease pathogenesis, including cardiocerebrovascular disorders, neurological disorders, metabolic diseases, cancer, reproductive disorders, and COVID-19. Finally, different therapeutic strategies for OSAS caused by different causes are proposed. Multidisciplinary approaches and shared decision-making are necessary for the successful treatment of OSAS in the future, but more randomized controlled trials are needed for further evaluation to define what treatments are best for specific OSAS patients.

Progress on treatment of obstructive sleep apnea hypopnea syndrome

Advancement on obstructive sleep apnea hypopnea syndrome [OSAHS] in last decade

Advances in Diagnosis and Treatment of Sleep Apnea Hypopnea Syndrome

[Individualized Threatment of Patients with Obstructive Sleep Apea-Hypopnea Syndrome].

[Novel advances in assessment and treatment of obstructive sleep apnea]

Research and current therapy of obstructive sleep apnea-related pulmonary hypertension

Research progress of a novel nasal expiratory positive airway pressure device for the treatment of obstructive sleep apnea hypopnea syndrome

Research on the Compliance for OSAHS Patients Treated by CPAP

The Research Progress of Obstructive Sleep Apnea-Hypopnea Syndrome and Hypothalamic-Pituitary-adrenal Axis

Improve compliance of patients with sleep apnea/hypopnea syndrome by health education and regular follow-up

[Oral Treatment for Obstructive Sleep Apnea Syndrome].

The latest research progress on the relationship between obstructive sleep apnea–hypopnea syndrome and metabolic syndrome

[Screening of sleep apnea syndrome-a review of current situation].

Research Progress in Kidney Disease Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

[Dentistry for Obstructive Sleep Apnea Hypopnea Syndrome].

Analysis of the improvement of quality of life in patients with obstructive sleep apnea hypopnea syndromes associated hypertension with continuous positive airway pressure

Obstructive sleep apnea syndrome treated by continous positive airway pressure

Obstructive sleep apnea hypopnea syndrome in ancient traditional Chinese medicine

Development of the Research on the Inflammatory Factors Related to Obstructive Sleep Apnea Hypopnea Syndrome and Therapy

Research progress on the relationship between obstructive sleep apnea syndrome and diseases of the respiratory and circulatory systems